贸易 OVID

Ovid Therapeutics Inc

-

00:00:00

Ovid Therapeutics Inc., a biopharmaceutical company, develops impactful medicines for patients and families with neurological disorders in the United States. The company is developing OV101, a drug candidate, which is in Phase 2A clinical trials for the treatment of fragile X syndrome; OV329, a GABA aminotransferase inhibitor for the treatment of seizures associated with tuberous sclerosis complex and infantile spasms; and OV350, a small molecule for treating epilepsies. It also develops OV882, a short hairpin RNA gene therapy for the treatment of angelman syndrome; and OV815 for the treatment of kinesin-family of proteins associated neurological disorder. The company has license and collaboration agreements with Healx, AstraZeneca AB, H. Lundbeck A/S, and Northwestern University, as well as Marinus Pharmaceuticals, Inc. The company was incorporated in 2014 and is headquartered in New York, New York.
阅读全文...

OVID
交易规格

数字

3

0.001

传播

floating

合同规模

1

体积最小

1

最大音量

10,000

卷阶

1

交换多头(点数)

-0.460

空头互换(点数)

-0.270
可在
MT5, TV, cTrader
最后更新时间为 17 6 月, 16:04 GMT+3
*数据来源MT5 服务器 Prime 账户定价

OVID
经济日历

未找到数据

1D 变化

206.604%

为什么选择黑牛 市场?

26k+

可交易资产

1:500

杠杆率高达

受监管

多重监管

24/7

客户支持

$0

无最低存款额

保证金计算器

Calculation Results

Current Price

1.01

Required Margin

Converted Currency

Required Margin

Account Base Currency

盈亏计算器

Calculation Results

PIP Value:

Stop loss in PIPs

Stop loss at :

Take profit in PIPs

Take profit at :

掉期计算器

Calculation Results

1.01

交易机会

未找到数据
Join Now